CMS advised Discovery Life Sciences on the deal. Büsing Müffelmann & Theye advised the shareholders of Targos Molecular Pathology .The US-American biosample and biomarker specialist Discovery…
Discovery Life Sciences’ Acquisition Of Targos Molecular Pathology GmbH

























